IA
ORGO icon

IndexIQ Advisors’s Organogenesis Holdings ORGO Stock Holding History

IndexIQ Advisors’s Portfolio ORGO Stock Details ORGO Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2022
Q1 		– Sell
-23,178
Closed -$214K – 1450
2021
Q4 		$214K Sell
23,178
-1,498
-6% -$15.9K 0.01% 1024
2021
Q3 		$351K Buy
24,676
+2,472
+11% +$38.4K 0.01% 916
2021
Q2 		$369K Buy
22,204
+115
+0.5% +$2.14K 0.01% 859
2021
Q1 		$402K Buy
+22,089
New +$299K 0.01% 657

Other funds holding ORGO

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
DM
Deerfield Management New York $8.48B AUM 99.04% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
SCM
Soleus Capital Management Greenwich, Connecticut $2.47B AUM 115.63% 1-Year Est. Return
GIM
Granahan Investment Management Waltham, Massachusetts $2.07B AUM 56.45% 1-Year Est. Return
Assenagon Asset Management
Assenagon Asset Management Senningerberg, Luxembourg $80.2B AUM 50.57% 1-Year Est. Return
Millennium Management
Millennium Management New York $240B AUM 35.51% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

IndexIQ Advisors's ORGO Position: Q1 2022 in Review

IndexIQ Advisors sold out of Organogenesis Holdings (ORGO) in Q1 2022, closing a stake of 23,178 shares — an estimated $214K sold.

IndexIQ Advisors first reported a position in ORGO in Q1 2021 and held it in 4 quarters. The position peaked at $402K in Q1 2021. 156 funds tracked by Wall St. Rank hold ORGO as of Q1 2022.

  • IndexIQ Advisors reported no remaining Organogenesis Holdings position as of Q1 2022 after selling out during the quarter.
  • IndexIQ Advisors sold 23,178 Organogenesis Holdings shares in Q1 2022, an estimated $214K.
  • IndexIQ Advisors first reported a position in Organogenesis Holdings in Q1 2021 and held it in 4 quarters.
  • IndexIQ Advisors's Organogenesis Holdings position peaked at $402K in Q1 2021.
  • 156 funds tracked by Wall St. Rank held Organogenesis Holdings as of Q1 2022.

Based on IndexIQ Advisors's 13F filing for Q1 2022, filed 6 May 2022.